[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Cancer Biomarkers Market Research Report 2016

October 2016 | 116 pages | ID: C1E57CA9B71EN
QYResearch

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Cancer Biomarkers

Revenue, means the sales value of Cancer Biomarkers

This report studies Cancer Biomarkers in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
  • Abbott Laboratories (U.S.)
  • Affymetrix Inc. (U.S.)
  • Roche Diagnostics Ltd. (Switzerland)
  • Illumina, Inc. (U.S.)
  • Qiagen NV (Netherlands)
  • Agilent Technologies (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Merck & Co. Inc. (U.S.)
  • Becton Dickinson and Company (U.S.)
  • Hologic Inc. (U.S.)
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Protein Biomarkers
  • Genetic Biomarkers
  • Others
Split by Application, this report focuses on consumption, market share and growth rate of Cancer Biomarkers in each application, can be divided into
  • Diagnostics
  • Drug Discovery and Development
  • Prognostics
  • Risk Assessment
  • Others?
China Cancer Biomarkers Market Research Report 2016

1 CANCER BIOMARKERS MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Cancer Biomarkers Segment by Type
  1.2.1 China Production Market Share of Cancer Biomarkers Type in 2015
  1.2.2 Protein Biomarkers
  1.2.3 Genetic Biomarkers
  1.2.4 Others
1.3 Applications of Cancer Biomarkers
  1.3.1 Cancer Biomarkers Consumption Market Share by Application in 2015
  1.3.2 Diagnostics
  1.3.3 Drug Discovery and Development
  1.3.4 Prognostics
  1.3.5 Risk Assessment
  1.3.6 Others?
1.4 China Market Size (Value) of Cancer Biomarkers (2011-2021)
1.5 China Cancer BiomarkersStatus and Outlook
1.6 Government Policies

2 CHINA CANCER BIOMARKERS MARKET COMPETITION BY MANUFACTURERS

2.1 China Cancer Biomarkers Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Cancer Biomarkers Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Cancer Biomarkers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Biomarkers Market Competitive Situation and Trends
  2.5.1 Cancer Biomarkers Market Concentration Rate
  2.5.2 Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers

3 CHINA CANCER BIOMARKERS MANUFACTURERS PROFILES/ANALYSIS

3.1 Abbott Laboratories (U.S.)
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Cancer Biomarkers Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Affymetrix Inc. (U.S.)
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 116 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 Affymetrix Inc. (U.S.) 116 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Roche Diagnostics Ltd. (Switzerland)
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 128 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Roche Diagnostics Ltd. (Switzerland) 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Illumina, Inc. (U.S.)
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Oct Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 Illumina, Inc. (U.S.) Oct Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Qiagen NV (Netherlands)
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 Qiagen NV (Netherlands) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Agilent Technologies (U.S.)
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Million USD Product Type, Application and Specification
    3.6.2.1 Type I
    3.6.2.2 Type II
  3.6.3 Agilent Technologies (U.S.) Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Thermo Fisher Scientific Inc. (U.S.)
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Biotechnology Product Type, Application and Specification
    3.7.2.1 Type I
    3.7.2.2 Type II
  3.7.3 Thermo Fisher Scientific Inc. (U.S.) Biotechnology Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Merck & Co. Inc. (U.S.)
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Product Type, Application and Specification
    3.8.2.1 Type I
    3.8.2.2 Type II
  3.8.3 Merck & Co. Inc. (U.S.) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Becton Dickinson and Company (U.S.)
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Product Type, Application and Specification
    3.9.2.1 Type I
    3.9.2.2 Type II
  3.9.3 Becton Dickinson and Company (U.S.) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Hologic Inc. (U.S.)
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Product Type, Application and Specification
    3.10.2.1 Type I
    3.10.2.2 Type II
  3.10.3 Hologic Inc. (U.S.) Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview

4 CHINA CANCER BIOMARKERS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Cancer Biomarkers Capacity, Production and Growth (2011-2016)
4.2 China Cancer Biomarkers Revenue and Growth (2011-2016)
4.3 China Cancer Biomarkers Production, Consumption, Export and Import (2011-2016)

5 CHINA CANCER BIOMARKERS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Cancer Biomarkers Production and Market Share by Type (2011-2016)
5.2 China Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
5.3 China Cancer Biomarkers Price by Type (2011-2016)
5.4 China Cancer Biomarkers Production Growth by Type (2011-2016)

6 CHINA CANCER BIOMARKERS MARKET ANALYSIS BY APPLICATION

6.1 China Cancer Biomarkers Consumption and Market Share by Application (2011-2016)
6.2 China Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CANCER BIOMARKERS MANUFACTURING COST ANALYSIS

7.1 Cancer Biomarkers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Biomarkers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA CANCER BIOMARKERS MARKET FORECAST (2016-2021)

11.1 China Cancer Biomarkers Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Cancer Biomarkers Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Cancer Biomarkers Production Forecast by Type (2016-2021)
11.4 China Cancer Biomarkers Consumption Forecast by Application (2016-2021)
11.5 Cancer Biomarkers Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
LIST OF TABLES AND FIGURES

Figure Picture of Cancer Biomarkers
Figure China Production Market Share of Cancer Biomarkers by Type in 2015
Figure Product Picture of Protein Biomarkers
Table Major Manufacturers of Protein Biomarkers
Figure Product Picture of Genetic Biomarkers
Table Major Manufacturers of Genetic Biomarkers
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Cancer Biomarkers Consumption Market Share by Application in 2015
Figure Diagnostics Examples
Figure Drug Discovery and Development Examples
Figure Prognostics Examples
Figure Risk Assessment Examples
Figure Others? Examples
Figure China Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)
Table China Cancer Biomarkers Capacity of Key Manufacturers (2015 and 2016)
Table China Cancer Biomarkers Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Cancer Biomarkers Capacity of Key Manufacturers in 2015
Figure China Cancer Biomarkers Capacity of Key Manufacturers in 2016
Table China Cancer Biomarkers Production of Key Manufacturers (2015 and 2016)
Table China Cancer Biomarkers Production Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Production Share by Manufacturers
Figure 2016 Cancer Biomarkers Production Share by Manufacturers
Table China Cancer Biomarkers Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 China Cancer Biomarkers Revenue Share by Manufacturers
Table China Market Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Cancer Biomarkers Average Price of Key Manufacturers in 2015
Table Manufacturers Cancer Biomarkers Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Biomarkers Product Type
Figure Cancer Biomarkers Market Share of Top 3 Manufacturers
Figure Cancer Biomarkers Market Share of Top 5 Manufacturers
Table Abbott Laboratories (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Affymetrix Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Illumina, Inc. (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Illumina, Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Qiagen NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qiagen NV (Netherlands) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Qiagen NV (Netherlands) Cancer Biomarkers Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agilent Technologies (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Agilent Technologies (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Merck & Co. Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co. Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Becton Dickinson and Company (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Becton Dickinson and Company (U.S.) Cancer Biomarkers Market Share (2011-2016)
Table Hologic Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hologic Inc. (U.S.) Cancer Biomarkers Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hologic Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)
Figure China Cancer Biomarkers Capacity, Production and Growth (2011-2016)
Figure China Cancer Biomarkers Revenue (Million USD) and Growth (2011-2016)
Table China Cancer Biomarkers Production, Consumption, Export and Import (2011-2016)
Table China Cancer Biomarkers Production by Type (2011-2016)
Table China Cancer Biomarkers Production Share by Type (2011-2016)
Figure Production Market Share of Cancer Biomarkers by Type (2011-2016)
Figure 2015 Production Market Share of Cancer Biomarkers by Type
Table China Cancer Biomarkers Revenue by Type (2011-2016)
Table China Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Cancer Biomarkers by Type (2011-2016)
Figure 2015 Revenue Market Share of Cancer Biomarkers by Type
Table China Cancer Biomarkers Price by Type (2011-2016)
Figure China Cancer Biomarkers Production Growth by Type (2011-2016)
Table China Cancer Biomarkers Consumption by Application (2011-2016)
Table China Cancer Biomarkers Consumption Market Share by Application (2011-2016)
Figure China Cancer Biomarkers Consumption Market Share by Application in 2015
Table China Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
Figure China Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure China Cancer Biomarkers Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table China Cancer Biomarkers Production, Import, Export and Consumption Forecast (2016-2021)
Table China Cancer Biomarkers Production Forecast by Type (2016-2021)
Table China Cancer Biomarkers Consumption Forecast by Application (2016-2021)


More Publications